ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 5,860.00
-210.00 (-3.46%)
Jul 21, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 64.63 billion as of July 21, 2026. Its market cap has decreased by -52.46% in one year.
Market Cap
64.63B
Enterprise Value
42.84B
Revenue
4.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,860.00
ChartMarket Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 64.63B, a decrease of -59.81%. That is a compound annual growth rate of -37.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 64.63B | -67.44% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 127.17B |
| Genexine | 104.15B |
| Vaxcell-Bio Therapeutics | 96.40B |
| MedPacto | 92.37B |
| Amicogen | 82.36B |
| iNtRON Biotechnology | 79.35B |
| CG Invites | 67.97B |
| Prestige BioPharma | 63.58B |